EC Number   |
Title |
Organism |
|---|
   3.4.21.2 | Evaluation of the pathogenic significance of the novel p.T58M chymotrypsin C variant in recurrent acute pancreatitis |
Homo sapiens |
| 3.4.21.2 | Mesotrypsin signature mutation in a chymotrypsin C (CTRC) variant associated with chronic pancreatitis |
Homo sapiens |
| 3.4.21.2 | Tighter control by chymotrypsin C (CTRC) explains lack of association between human anionic trypsinogen and hereditary pancreatitis |
Homo sapiens |
| 3.4.21.2 | Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknechts enzyme Y |
Homo sapiens |
| 3.4.21.2 | Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen |
Homo sapiens |
| 3.4.21.2 | Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis |
Homo sapiens |
| 3.4.21.2 | Chymotrypsin C. I. Isolation of the zymogen and the active enzyme: preliminary structure and specificity studies |
Sus scrofa |
| 3.4.21.2 | Chymotrypsin C. II. Enzymatic specificity toward several polypeptides |
Sus scrofa |
| 3.4.21.2 | Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk |
Homo sapiens |
| 3.4.21.2 | Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen |
Homo sapiens |
